Vasu Miduturu

Vasu Miduturu has extensive experience in the field of pharmacovigilance and drug safety. Vasu currently holds the role of Director of Pharmacovigilance Operations at Tango Therapeutics since 2023. Prior to this, Vasu worked at EQRx as the Director of Pharmacovigilance Systems & Operations from 2020 to 2023, and as the Associate Director of Pharmacovigilance Systems & Operations from 2020 to 2022. Before joining EQRx, they were the Associate Director of Drug Safety & Pharmacovigilance at Blueprint Medicines in 2020. Vasu also served as the Senior Manager of Drug Safety & Pharmacovigilance at Blueprint Medicines from 2018 to 2019. In addition to these roles, Vasu has held positions at Boston Biomedical as the Manager of Pharmacovigilance, Assistant Project Manager of Pharmacovigilance, and Clinical Research Associate from 2015 to 2018. Vasu began their career as a Clinical Safety Associate at Brigham & Women's Hospital in 2014. From 2007 to 2013, Vasu worked as a Scientific Associate at Novartis, and prior to that, they were an Associate Research Scientist at Bristol-Myers Squibb from 2003 to 2007.

Vasu Miduturu holds a Biotechnology Project Management Certificate from the Massachusetts Biotechnology Education Foundation, completed in 2013. In 2011, they also obtained a Regulatory Affairs Certificate in Pharmaceuticals from RAPS Online University. Prior to this, Vasu pursued a Master's degree in Chemistry at the University of Pittsburgh from 2000 to 2003, and another Master's degree in Chemistry from the Indian Institute of Technology, Madras from 1998 to 2000. Vasu'seducational journey began with a Bachelor's degree in Chemistry from Ethiraj College, University of Madras, which they completed from 1995 to 1998.